Brightside Health, a San Francisco, CA-based telemental health company, raised $33M in Series C funding.
The round, which brought total funding raised to date to $100m, was led by S32 with Trip Hofer joining the Board of Directors. Kennedy Lewis, Time BioVentures, and Anne Wojcicki (Redwood Pacific), and existing investors ACME, Mousse Partners, and Triventures also participated.
The company intends to use the use the funds to expand operations and its business reach in new markets.
Led by CEO Brad Kittredge, Brightside Health delivers mental health care to people with mild to severe clinical depression, anxiety, and other mood disorders, including those with elevated suicide risk. Empowered by proprietary AI, purpose-built technology, and a clinician network, the company combines precision psychiatry and therapeutic techniques to improve patient outcomes across the entire clinical spectrum, at scale. Brightside Health can be paid for with insurance in all 50 states and D.C., with appointments available in 48 hours or less.
FinSMEs
27/03/2024